
Genesys (GENESYS) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
941.6M
Gross Profit
570.9M
60.63%
Operating Income
344.9M
36.63%
Net Income
190.0M
20.17%
Balance Sheet Metrics
Total Assets
7.8B
Total Liabilities
2.2B
Shareholders Equity
5.6B
Debt to Equity
0.40
Cash Flow Metrics
Revenue & Profitability Trend
Genesys Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 3.1B | 2.0B | 1.8B | 1.2B | 795.6M |
Cost of Goods Sold | 1.4B | 916.2M | 960.5M | 806.7M | 640.7M |
Gross Profit | 1.7B | 1.1B | 850.7M | 358.4M | 154.9M |
Gross Margin % | 54.5% | 53.8% | 47.0% | 30.8% | 19.5% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 72.5M | 81.6M | 37.0M | 30.0M |
Other Operating Expenses | 272.8M | 82.2M | 104.7M | 62.4M | 109.1M |
Total Operating Expenses | 272.8M | 154.7M | 186.3M | 99.4M | 139.1M |
Operating Income | 871.0M | 388.6M | 215.6M | 92.4M | -180.5M |
Operating Margin % | 28.0% | 19.6% | 11.9% | 7.9% | -22.7% |
Non-Operating Items | |||||
Interest Income | - | 8.8M | 3.8M | 3.1M | 1.6M |
Interest Expense | 87.8M | 39.1M | 26.7M | 24.8M | 38.9M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 826.8M | 371.8M | 250.0M | -358.7M | -544.4M |
Income Tax | 265.7M | 155.6M | 100.6M | 38.2M | -26.6M |
Effective Tax Rate % | 32.1% | 41.9% | 40.3% | 0.0% | 0.0% |
Net Income | 561.0M | 216.1M | 149.3M | -396.9M | -517.9M |
Net Margin % | 18.0% | 10.9% | 8.2% | -34.1% | -65.1% |
Key Metrics | |||||
EBITDA | 1.5B | 843.1M | 627.9M | 307.2M | 6.1M |
EPS (Basic) | ₹14.14 | ₹5.78 | ₹5.44 | ₹4.28 | ₹-13.77 |
EPS (Diluted) | ₹14.03 | ₹5.74 | ₹5.29 | ₹4.13 | ₹-13.77 |
Basic Shares Outstanding | 39761810 | 38160656 | 35147151 | 31247559 | 31177186 |
Diluted Shares Outstanding | 39761810 | 38160656 | 35147151 | 31247559 | 31177186 |
Income Statement Trend
Genesys Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 33.4M | 232.7M | 125.6M | 213.8M | 13.8M |
Short-term Investments | 2.2B | 3.9M | 515.1M | 61.9M | 81.7M |
Accounts Receivable | 2.2B | 1.4B | 832.2M | 491.5M | 323.0M |
Inventory | - | - | - | - | - |
Other Current Assets | 87.2M | 113.3M | 130.0M | 91.7M | 55.5M |
Total Current Assets | 4.6B | 3.3B | 2.4B | 1.3B | 752.7M |
Non-Current Assets | |||||
Property, Plant & Equipment | 667.6M | 816.6M | 619.5M | 416.1M | 398.9M |
Goodwill | 2.1B | 1.9B | 1.6B | 1.2B | 2.0B |
Intangible Assets | 2.1B | 1.9B | 1.6B | 1.2B | 1.3B |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 45.2M | 38.6M | -1.0K | 2.4M | 11.7M |
Total Non-Current Assets | 3.2B | 3.0B | 2.6B | 1.9B | 2.3B |
Total Assets | 7.8B | 6.3B | 5.1B | 3.2B | 3.0B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 370.5M | 296.5M | 222.3M | 239.8M | 129.8M |
Short-term Debt | 999.0M | 323.4M | 175.0M | 223.7M | 84.8M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 76.4M | 95.1M | 30.7M | 26.2M | 15.0M |
Total Current Liabilities | 1.9B | 1.1B | 690.8M | 730.5M | 367.4M |
Non-Current Liabilities | |||||
Long-term Debt | 222.6M | 271.8M | 218.1M | 41.3M | 51.3M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | - | - | - | 40.0K |
Total Non-Current Liabilities | 317.2M | 349.7M | 290.6M | 101.0M | 124.2M |
Total Liabilities | 2.2B | 1.4B | 981.3M | 831.5M | 491.6M |
Equity | |||||
Common Stock | 199.0M | 197.7M | 188.8M | 156.8M | 156.1M |
Retained Earnings | - | 723.7M | 595.9M | 833.1M | 814.8M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 5.6B | 4.9B | 4.1B | 2.4B | 2.5B |
Key Metrics | |||||
Total Debt | 1.2B | 595.2M | 393.2M | 265.0M | 136.1M |
Working Capital | 2.7B | 2.2B | 1.7B | 549.8M | 385.3M |
Balance Sheet Composition
Genesys Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 826.8M | 371.8M | 250.0M | -358.7M | -544.4M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 29.7M | 31.6M | 26.9M | 14.2M | - |
Working Capital Changes | -2.0B | -751.4M | -914.7M | -95.0M | 173.8M |
Operating Cash Flow | -1.1B | -327.1M | -696.4M | -491.3M | -444.0M |
Investing Activities | |||||
Capital Expenditures | -433.7M | -732.9M | -851.9M | -83.6M | -77.8M |
Acquisitions | - | 0 | -532.6M | 0 | - |
Investment Purchases | 0 | -1.3B | -1.8B | -386.1M | -512.3M |
Investment Sales | 351.8M | 1.3B | 1.4B | 413.3M | 483.1M |
Investing Cash Flow | -81.9M | -702.6M | -1.8B | -50.0M | -107.0M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 28.2M | 161.2M | 236.0M | - | - |
Debt Repayment | -97.0M | -72.3M | -26.0M | - | - |
Financing Cash Flow | 631.2M | 780.0M | 2.2B | 164.6M | -41.0M |
Free Cash Flow | -1.1B | -645.8M | -1.3B | -50.2M | 95.0M |
Net Change in Cash | -517.4M | -249.8M | -226.6M | -376.6M | -592.0M |
Cash Flow Trend
Genesys Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
41.84
Forward P/E
43.17
Price to Book
4.20
Price to Sales
7.51
PEG Ratio
43.17
Profitability Ratios
Profit Margin
17.78%
Operating Margin
21.27%
Return on Equity
10.09%
Return on Assets
7.23%
Financial Health
Current Ratio
2.41
Debt to Equity
21.93
Per Share Data
EPS (TTM)
₹14.03
Book Value per Share
₹139.86
Revenue per Share
₹81.72
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
genesys | 24.5B | 41.84 | 4.20 | 10.09% | 17.78% | 21.93 |
Tata Elxsi | 353.9B | 47.39 | 12.37 | 27.45% | 20.00% | 6.72 |
KFin Technologies | 194.4B | 57.13 | 13.78 | 23.63% | 29.29% | 3.31 |
Network People | 44.6B | 121.98 | 43.02 | 43.26% | 24.81% | 9.18 |
63 Moons | 42.9B | 42.53 | 1.25 | -0.97% | -32.75% | 0.08 |
Technvision Ventures | 26.4B | 10,361.11 | 340.38 | 0.70% | -0.86% | 25.93 |
Financial data is updated regularly. All figures are in the company's reporting currency.